A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study
Giulia Maggioni(Humanitas University), Uwe Platzbecker(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Elisabetta Sauta(Humanitas University), Francesco Passamonti(University of Insubria), Saverio D’Amico(Humanitas University), Kathrin Nachtkamp(Leukemia and Lymphoma Society), Arjan A. van de Loosdrecht(Amsterdam UMC Location Vrije Universiteit Amsterdam), Tommaso Matteuzzi(Leukemia and Lymphoma Society), Victor Savevski(Humanitas University), Alessia Campagna(Humanitas University), Matteo Zampini(Humanitas University), Erica Travaglino(Policlinico San Matteo Fondazione), Massimo Bernardi(Vita-Salute San Raffaele University), Anne Sophie Kubasch(Leukemia and Lymphoma Society), Ana Alfonso Piérola(Istituti di Ricovero e Cura a Carattere Scientifico), Arnan Sangerman Montserrat(Ministero della Salute), Matteo Gnocchi(Leukemia and Lymphoma Society), Marilena Bicchieri(Humanitas University), Claudia Sala, Daniele Dall’Olio, Manja Meggendorfer(Université Paris-Sud), Norbert Gattermann(Institute of Biomedical Science), Francesca Re(University of Milano-Bicocca), Giovanni Angelotti(Leukemia and Lymphoma Society), Cristina Astrid Tentori(IRCCS Humanitas Research Hospital), Wolfgang Kern(Munich Leukemia Laboratory (Germany)), Shahram Kordasti(Guy's Hospital), Matteo Bersanelli(Humanitas University), Benedetta Tinterri(Ministero della Salute), Guillermo Sanz(Instituto de Salud Carlos III), Elena Saba(Istituti di Ricovero e Cura a Carattere Scientifico), Esther Natalie Olíva(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Alice Brogi(Leukemia and Lymphoma Society), Maria Teresa Voso(University of Rome Tor Vergata), Lin‐Pierre Zhao, Marta Ubezio(Humanitas University), Giulia Rivoli(Ospedale Policlinico San Martino), Pierandrea Morandini(IRCCS Humanitas Research Hospital), Françesc Solé(Fundación Josep Carreras Contra la Leucemia), Laura Giordano(Istituti di Ricovero e Cura a Carattere Scientifico), Ettore Mosca(Institute of Biomedical Technologies), Luca Lanino(Humanitas University), Valeria Santini(University of Florence), Armando Santoro(IRCCS Humanitas Research Hospital), Antonio Russo(Humanitas University), Lorenza Borin(Azienda Ospedaliera San Gerardo), Marta Riva(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Annika Kasprzak(Leukemia and Lymphoma Society), Elena Riva(Humanitas University)
Cited by 34
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821